420 related articles for article (PubMed ID: 28238669)
21. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
[TBL] [Abstract][Full Text] [Related]
22. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells.
Parga JA; Rodriguez-Perez AI; Garcia-Garrote M; Rodriguez-Pallares J; Labandeira-Garcia JL
Free Radic Biol Med; 2018 Dec; 129():394-406. PubMed ID: 30315936
[TBL] [Abstract][Full Text] [Related]
24. Suppression of 6-Hydroxydopamine-Induced Oxidative Stress by Hyperoside Via Activation of Nrf2/HO-1 Signaling in Dopaminergic Neurons.
Kwon SH; Lee SR; Park YJ; Ra M; Lee Y; Pang C; Kim KH
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757050
[TBL] [Abstract][Full Text] [Related]
25. The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.
Zare K; Eidi A; Roghani M; Rohani AH
Metab Brain Dis; 2015 Feb; 30(1):205-13. PubMed ID: 25123753
[TBL] [Abstract][Full Text] [Related]
26. SMER28 Attenuates Dopaminergic Toxicity Mediated by 6-Hydroxydopamine in the Rats via Modulating Oxidative Burdens and Autophagy-Related Parameters.
Darabi S; Noori-Zadeh A; Rajaei F; Abbaszadeh HA; Bakhtiyari S; Roozbahany NA
Neurochem Res; 2018 Dec; 43(12):2313-2323. PubMed ID: 30288644
[TBL] [Abstract][Full Text] [Related]
27. [Effect and mechanism of moxibustion on oxidative stress injury in rats with Parkinson's disease by activating Nrf2/ARE pathway].
Liu XL; Lu J; Tian Y; Zhang GY; Zhao CP; Wang TT; Li XR; Zhu ML
Zhongguo Zhen Jiu; 2020 Aug; 40(8):857-62. PubMed ID: 32869595
[TBL] [Abstract][Full Text] [Related]
28. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
[TBL] [Abstract][Full Text] [Related]
29. Safranal prevents rotenone-induced oxidative stress and apoptosis in an in vitro model of Parkinson's disease through regulating Keap1/Nrf2 signaling pathway.
Pan PK; Qiao LY; Wen XN
Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):11-17. PubMed ID: 28145852
[TBL] [Abstract][Full Text] [Related]
30. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
Rai SN; Yadav SK; Singh D; Singh SP
J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion.
Cutillas B; Ambrosio S; Unzeta M
Neurosci Lett; 2002 Aug; 329(2):165-8. PubMed ID: 12165403
[TBL] [Abstract][Full Text] [Related]
32. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease.
Khan MM; Raza SS; Javed H; Ahmad A; Khan A; Islam F; Safhi MM; Islam F
Neurotox Res; 2012 Jul; 22(1):1-15. PubMed ID: 22194158
[TBL] [Abstract][Full Text] [Related]
33. IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases.
Ayadi AE; Zigmond MJ; Smith AD
Exp Brain Res; 2016 Jul; 234(7):1863-1873. PubMed ID: 26894890
[TBL] [Abstract][Full Text] [Related]
34. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
[TBL] [Abstract][Full Text] [Related]
35. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
Stayte S; Rentsch P; Li KM; Vissel B
PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
[TBL] [Abstract][Full Text] [Related]
36. Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/HO-1 signaling.
Lu Q; Gouda NA; Quan G; Nada H; Elkamhawy A; Lee D; Lee CH; Cho J; Lee K
Eur J Med Chem; 2022 Nov; 242():114692. PubMed ID: 36029560
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: Role of NADPH oxidase-1.
Zhang FL; He Y; Zheng Y; Zhang WJ; Wang Q; Jia YJ; Song HL; An HT; Zhang HB; Qian YJ; Tong YL; Dong L; Wang XM
CNS Neurosci Ther; 2014 Dec; 20(12):1036-44. PubMed ID: 25399812
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
[TBL] [Abstract][Full Text] [Related]
39. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.
Cui Q; Li X; Zhu H
Mol Med Rep; 2016 Feb; 13(2):1381-8. PubMed ID: 26648392
[TBL] [Abstract][Full Text] [Related]
40. The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death.
Mertens B; Varcin M; Michotte Y; Sarre S
Eur J Neurosci; 2011 Oct; 34(7):1141-8. PubMed ID: 21936877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
